US equities
|
MU
$904.90
▲+2.97%
NVDA
$217.09
▲+1.38%
AMZN
$262.45
▲+4.98%
TSLA
$368.06
▲+3.76%
AAPL
$342.94
▼-0.15%
SNDK
$1,371.12
▲+5.53%
META
$705.44
▼-0.55%
SPCX
$147.96
▲+1.32%
MU
$904.90
▲+2.97%
NVDA
$217.09
▲+1.38%
AMZN
$262.45
▲+4.98%
TSLA
$368.06
▲+3.76%
AAPL
$342.94
▼-0.15%
SNDK
$1,371.12
▲+5.53%
META
$705.44
▼-0.55%
SPCX
$147.96
▲+1.32%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about NASDAQ:MYNZ
Recent news which mentions NASDAQ:MYNZ
Mainz BioMed Seeks FDA Breakthrough Device Designation for Advanced Colorectal Cancer Test
July 19, 2024
Tags
NASDAQ:MYNZ
From
News Direct
MYNZ Stock Earnings: Mainz Biomed Beats EPS, Misses Revenue for Q4 2023
April 09, 2024
Tickers
MYNZ
Tags
NASDAQ:MYNZ
MYNZ
Market News
From
InvestorPlace